Max Robotics — Global Service Robot Directory + US Certification

About

Francesco Fanfani is an emerging force in gynecologic oncology, with research centered on minimally invasive and robotic-assisted surgery for the treatment of endometrial cancer, endometriosis, and related gynecological conditions. His work sits at the intersection of surgical innovation and patient outcomes, investigating how advanced technologies — including robotic platforms, artificial intelligence, and image-guided surgery — can be harnessed to improve care for complex patient populations. Fanfani has made notable contributions by rigorously evaluating the real-world benefits of robotic surgery, particularly for high-risk groups such as severely obese and frail patients with endometrial cancer, where his propensity-matched analyses provide valuable clinical guidance. His comparative studies, including the multi-center "Clash of the Titans" trial pitting the da Vinci against the Hugo™ RAS system, reflect his commitment to evidence-based assessment of emerging surgical technologies. His investigations into single-port techniques and minimally invasive approaches for recurrent endometrial cancer further underscore his drive to expand surgical options while minimizing patient burden. With publications accumulating over 35 citations in just the past year alone, Fanfani's research is gaining rapid traction within the gynecologic surgery community, positioning him as a promising contributor to the evolution of precision surgical oncology.